M
MBG
Specialist
- Jul 14, 2023
- 377
Magic Mushroom Treatment Takes a Big Step Toward FDA Approval – Here’s What Changed
Compass Pathways' synthetic psilocybin COMP360 clears Phase 3 trials, showing 39% depression reduction in 24 hours for treatment-resistant patients.
The "magical" chemical behind Magic Mushrooms just passed two Phase 3 clinical trials. Next stop is getting FDA approval and then DEA rescheduling. If successful (probably another 6 to 12 months) this will be a major advancement for the treatment of depression.